ASCO GU 2024: Updates in the Treatment of Advanced Renal Cell Carcinoma - Episode 8

Clinical Pearls for Managing IO-TKI and IO-IO Toxicity in Advanced RCC

, , , ,

Medical oncologists provide clinical insights on managing adverse events associated with IO-TKI and IO-IO regimens in patients with advanced renal cell carcinoma.